Collaborative multidisciplinary workshop report: clinical antimicrobial trials for primary and secondary prevention of atherosclerotic cardiovascular disease.
The task assigned to the working group on Clinical Antimicrobial Trials for Primary and/or Secondary Prevention of Atherosclerotic Cardiovascular Disease was to evaluate the need for additional clinical antibiotic trials of a primary or secondary nature for the treatment of atherosclerotic heart disease and to suggest possible designs for future trials. In addition, the working group was to define the role of collaboration in answering research questions.
Rosen
H
H
Department of Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA.
Muhlestein
J B
JB
Bartlett
J
J
Chen
S
S
Chikami
G
G
Corson
M
M
Shah
P K
PK
Gurfinkel
E
E
Handsfield
H
H
Jackson
L
L
Knirsch
C
C
Kronmal
R
R
McCutchan
J A
JA
Shea
S
S
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002690:Chlamydia Infections / Q000150:complications / Q000188:drug therapy*; D016993:Chlamydophila pneumoniae; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control*; D006801:Humans
D000900:Anti-Bacterial Agents